Related Articles
Anlotinib‑induced acute myocardial infarction: A case report and literature review
Toripalimab combined with anlotinib for recurrent extensive‑stage small‑cell lung cancer: A case report
Anlotinib plus tislelizumab for recurrent metastatic pancreas ductal adenocarcinoma with germline BRCA2 mutation: A case report
Low‑dose anlotinib combined with EGFR‑TKI can be used as an alternative for EGFR‑TKI‑resistant non‑small cell lung cancer in elderly patients
Anlotinib as a molecular targeted therapy for tumors (Review)